NCT02624778: A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD
- State
- Completed
- Phase
- Phase 1
- People
- 61 taking part
- Started
- 22 Dec 2015
- Primary completion
- 28 Aug 2019
- Arms
- Part A: 10 Milligram Per Kilogram (mg/kg) LY3002813 SD, Part A: 20 mg/kg LY3002813 SD, Part A: 40 mg/kg LY3002813 SD, Part B: 10 mg/kg LY3002813 Q2W, Part C:10 mg/kg LY3002813 Q4W, Part C:20 mg/kg LY3002813 Q4W
- Results
- Posted on the registry
- 8 Dec 2015: Trial registered
- 22 Dec 2015: Trial started
- 28 Aug 2019: Trial completed
- 8 Oct 2024: Trial results posted